Cited by 1,828Substance Abuse Treatment and OutcomesAlcohol Consumption and Health EffectsAlcoholism and Thiamine Deficiency

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Naltrexone in the Treatment of Alcohol Dependence

Volpicelli, Joseph R.·1992·Archives of General Psychiatry

DOI 10.1001/archpsyc.1992.01820110040006

Open this paper in CoChat — free account

Abstract

Seventy male alcohol-dependent patients participated in a 12-week, double-blind, placebo-controlled trial of naltrexone hydrochloride (50 mg/d) as an adjunct to treatment following alcohol detoxification. Subjects taking naltrexone reported significantly less alcohol craving and days in which any alcohol was consumed. During the 12-week study, only 23% of the naltrexone-treated subjects met the criteria for a relapse, whereas 54.3% of the placebo-treated subjects relapsed. The primary effect of naltrexone was seen in patients who drank any alcohol while attending outpatient treatment. Nineteen (95%) of the 20 placebo-treated patients relapsed after they sampled alcohol, while only eight (50%) of 16 naltrexone-treated patients exposed to alcohol met relapse criteria. Naltrexone was not associated with mood changes or other psychiatric symptoms. Significant side effects (nausea) occurred in two naltrexone-treated subjects, and one naltrexone-treated subject complained of increased pain from arthritis. These results suggest that naltrexone may be a safe and effective adjunct to treatment in alcohol-dependent subjects, particularly in preventing alcohol relapse.

Integrity signals

Registry

Crossref · 10.1001/archpsyc.1992.01820110040006

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974) · Behavioral Science · doi:10.1002/bs.3830190102 · Cited by 4,604
Survival Analysis
Miller, R. G. (1981) · Cited by 3,336
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.256.11.1449 · Cited by 541
Alteration of ethanol self-administration by naltrexone
Altshuler, H. L., Phillips, P. E., & Feinhandler, D. A. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90257-x · Cited by 397
The Effectiveness of Alcoholism Treatment
Miller, W. R., & Hester, R. K. (1986) · Springer eBooks · doi:10.1007/978-1-4613-2191-0_7 · Cited by 276
The serotonin uptake inhibitor citalopram attenuates ethanol intake
Naranjo, C. A., Sellers, E. M., Sullivan, J. T., Woodley-Remus, D., Kadlec, K. E., & Sykora, K. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.27 · Cited by 236
Naltrexone blocks the post-shock increase of ethanol consumption
Volpicelli, J. R., Davis, M. A., & Olgin, J. E. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90601-6 · Cited by 187
Self-citation
Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey
Myers, R. D., Borg, S., & Mossberg, R. (1986) · Alcohol · doi:10.1016/0741-8329(86)90058-3 · Cited by 167
Lithium Treatment of Depressed and Nondepressed Alcoholics
Dorus, W. (1989) · JAMA · doi:10.1001/jama.1989.03430120100029 · Cited by 164
Oral ethanol self-administration in the rat: Effect of naloxone
Samson, H. H., & Doyle, T. F. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90491-5 · Cited by 162

Show all 23 references

Sorted by citations

Items 101–200 of 1,004

Monoamine transporters and psychostimulant addiction
Howell, L. L., & Kimmel, H. L. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.003 · Cited by 254
Pharmacogenetic approaches to the treatment of alcohol addiction
Heilig, M. A., Goldman, D. A., Berrettini, W. H., & O’Brien, C. P. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn3110 · Cited by 256
Genetic and environmental contributions to smoking
True, W. R., Heath, A. C., Scherrer, J. F., Waterman, B. M., Goldberg, J., Lin, N., Eisen, S. A., Lyons, M. J., & Tsuang, M. T. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02847.x · Cited by 248
A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol Dependence
Mason, B. J., Ritvo, E. C., Morgan, R. O., Salvato, F., Goldberg, G., Welch, B., & Mantero-Atienza, E. (1994) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00098.x · Cited by 243
Opioid antagonists for alcohol dependence
Rösner, S., Hackl-Herrwerth, A., Leucht, S., Vecchi, S., Srisurapanont, M., & Soyka, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867.pub3 · Cited by 255
Priority medicines for Europe and the world
Kaplan, W. A., Laing, R. O., & Neal, B. C. (2004) · Cited by 244
Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders
Tiffany, S. T., Friedman, L., Greenfield, S. F., Hasin, D. S., & Jackson, R. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03581.x · Cited by 236
Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment
Blomqvist, O., Ericson, M., Johnson, D. H., Engel, J. A., & Söderpalm, B. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00583-3 · Cited by 235
Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence
King, A. C., Volpicelli, J. R., Frazer, A., & O'Brien, C. P. (1997) · Psychopharmacology · doi:10.1007/s002130050156 · Cited by 227
Self-citation
Opioids and alcoholism
Oswald, L. M., & Wand, G. S. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.02.008 · Cited by 235
Naltrexone and Cue Exposure With Coping and Communication Skills Training for Alcoholics: Treatment Process and 1-Year Outcomes
Monti, P. M., Rohsenow, D. J., Swift, R. M., Gulliver, S. B., Colby, S. M., Mueller, T. I., Brown, R. A., Gordon, A. A., Abrams, D. B., NIAURA, R. S., et al. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02170.x · Cited by 233
Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol
Söderpalm, B., Ericson, M., Olausson, P., Blomqvist, O., & Engel, J. A. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00203-5 · Cited by 226
Effects of Naltrexone and Fluoxetine on Alcohol Self-Administration and Reinstatement of Alcohol Seeking Induced by Priming Injections of Alcohol and Exposure to Stress
Lê, A. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00024-x · Cited by 228
Neurobiology of relapse to alcohol in rats
Lê, A. D., & Shaham, Y. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00200-0 · Cited by 230
Neurocircuitry of alcohol addiction
Koob, G. F. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-62619-6.00003-3 · Cited by 238
Enhanced Sensitivity of Pituitary βEndorphin to Ethanol in Subjects at High Risk of Alcoholism
Gianoulakis, C. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830030072011 · Cited by 224
Targeted Use of Naltrexone Without Prior Detoxification in the Treatment of Alcohol Dependence: A Factorial Double-Blind, Placebo-Controlled Trial
Heinälä, P., Alho, H., Kiianmaa, K., Lönnqvist, J. K., Kuoppasalmi, K. I., & Sinclair, J. D. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200106000-00006 · Cited by 226
Compulsive sexual behavior: A review of the literature
Derbyshire, K. L., & Grant, J. E. (2015) · Journal of Behavioral Addictions · doi:10.1556/2006.4.2015.003 · Cited by 219
REVIEW: Alcohol‐related genes: contributions from studies with genetically engineered mice
Crabbe, J. C., Phillips, T. J., Harris, R. A., Arends, M. A., & Koob, G. F. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00038.x · Cited by 225
Medication-Assisted Treatment in Criminal Justice Agencies Affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, Barriers, and Intentions
Friedmann, P. D., Hoskinson, R. A., Gordon, M., Schwartz, R. P., Kinlock, T. W., Knight, K. K., Flynn, P. M., Welsh, W. N., Stein, L. A. R., Sacks, S., et al. (2012) · Substance Abuse · doi:10.1080/08897077.2011.611460 · Cited by 224
Critical assessment of how to study addiction and its treatment: Human and non-human animal models
O’Brien, C. P., & Gardner, E. L. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.018 · Cited by 224
Drugs of Abuse and the Brain
Leshner, A. I., & Koob, G. F. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.09218.x · Cited by 220
Neurochemical and behavioral studies on ethanol and nicotine interactions
Larsson, A. C., & Engel, J. A. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.11.010 · Cited by 224
Increased Attributable Risk Related to a Functional μ-Opioid Receptor Gene Polymorphism in Association with Alcohol Dependence in Central Sweden
Bart, G. B., Kreek, M. J., Ott, J., LaForge, K. S., Proudnikov, D., Pollak, L., & Heilig, M. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300598 · Cited by 220
The Safety Profile of Naltrexone in the Treatment of Alcoholism
Croop, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830240090013 · Cited by 220
Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials
Srisurapanont, M., & Jarusuraisin, N. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004997 · Cited by 215
Reinstatement of Alcohol-Seeking Behavior by Drug-Associated Discriminative Stimuli after Prolonged Extinction in the Rat
Katner, S. N. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00084-0 · Cited by 216
Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: The role of patient motivation
MASON, B., GOODMAN, A., Chabac, S., & Lehert, P. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.02.002 · Cited by 212
Imipramine Treatment of Alcoholics With Primary Depression
McGrath, P. J. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830030054009 · Cited by 212
Naltrexone vs. Nefazodone for Treatment of Alcohol Dependence A Placebo-Controlled Trial
Kranzler, H. R. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00135-9 · Cited by 207
Predicting Treatment Response to Naltrexone: The Influence of Craving and Family History
Monterosso, J. R., Flannery, B., Pettinati, H. M., Oslin, D. W., Rukstalis, M. R., O’Brien, C. P., & Volpicelli, J. R. (2001) · American Journal on Addictions · doi:10.1080/105504901750532148 · Cited by 208
Self-citation
Effect of Selective Blockade of μ1 or δ Opioid Receptors on Reinstatement of Alcohol-Seeking Behavior by Drug-Associated Stimuli in Rats,
Ciccocioppo, R. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00302-0 · Cited by 203
Ability of Baclofen in Reducing Alcohol Craving and Intake: II???Preliminary Clinical Evidence
Addolorato, G., Caputo, F., Capristo, E., G., C., Gessa, G. L., & Gasbarrini, A. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04555.x · Cited by 203
Pharmacotherapies for Treatment of Cocaine Abuse: Preclinical Aspects
Carroll, F. I., Howell, L. L., & Kuhar, M. J. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9706729 · Cited by 202
Pharmacotherapy of Alcohol Dependence
Mann, K. F. (2004) · CNS Drugs · doi:10.2165/00023210-200418080-00002 · Cited by 198
A dopamine‐μ1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non‐psychostimulant drugs of abuse
Tanda, G., & Chiara, G. D. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00135.x · Cited by 200
Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters.
Drewnowski, A., Krahn, D., Demitrack, M., Nairn, K., & Gosnell, B. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.6.1206 · Cited by 197
A Double-Blind, Placebo-Controlled Study of the Opiate Antagonist, Naltrexone, in the Treatment of Kleptomania
Grant, J. E., Kim, S. W., & Odlaug, B. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.022 · Cited by 195
Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism.
Gianoulakis, C. (2001) · PubMed Central · Cited by 193
Combined Efficacy of Acamprosate and Disulfiram in the Treatment of Alcoholism: A Controlled Study
Besson, J., Aeby, F., Kasas, A., Lehert, P., & Potgieter, A. S. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb04295.x · Cited by 191
Naltrexone in the treatment of alcoholism: A clinical review
O’Brien, C. P., Volpicelli‐Daley, L. A., & Volpicelli, J. R. (1996) · Alcohol · doi:10.1016/0741-8329(95)02038-1 · Cited by 189
Self-citation
A Comparison of Pathological Gamblers to Alcoholics and Cocaine Misusers on Impulsivity, Sensation Seeking, and Craving
Castellani, B. C., & Rugle, L. J. (1995) · International Journal of the Addictions · doi:10.3109/10826089509048726 · Cited by 188
Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine
Ericson, M., Blomqvist, O., Engel, J. A., & Söderpalm, B. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00602-5 · Cited by 188
Naltrexone's Effect on Cue‐Elicited Craving Among Alcoholics in Treatment
Monti, P. M., Rohsenow, D. J., Hutchison, K. E., Swift, R. M., Mueller, T. I., Colby, S. M., Brown, R. A., Gulliver, S. B., Gordon, A. A., & Abrams, D. B. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04361.x · Cited by 188
Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens
Zhang, M., & Kelley, A. E. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0932-y · Cited by 186
Research to practice
Parks, C. L., Wallack, S. S., Lee, S., McCarty, D. W., & Swift, R. M. (2003) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(02)00319-7 · Cited by 183
Alcohol Dependence, Withdrawal, and Relapse
Becker, H. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405941-2.00019-5 · Cited by 188
Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients
Pelc, I., Verbanck, P., Bon, O. L., Gavrilovic, M., Lion, K., & Lehert, P. (1997) · The British Journal of Psychiatry · doi:10.1192/bjp.171.1.73 · Cited by 180
Alcohol- and Drug-Use Disorders in Australia: Implications of the National Survey of Mental Health and Wellbeing
Teesson, M., Hall, W., Lynskey, M. T., & Degenhardt, L. J. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2000.00715.x · Cited by 230
Adoption and implementation of new technologies in substance abuse treatment
Roman, P. M., & Johnson, J. A. (2002) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(02)00241-6 · Cited by 177
Association of the κ-opioid system with alcohol dependence
Xuei, X., Dick, D. M., Wetherill, L. F., Tian, H.-J., Arpana Agrawal, A., Bierut, L. J., Goate, A., Bucholz, K. K., Schuckit, M. A., Nürnberger, J. I., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001882 · Cited by 179
Rational Development of Addiction Pharmacotherapies: Successes, Failures, and ProspectsPreprint
Pierce, R. C., O'Brien, C. P., Kenny, P. J., & Vanderschuren, L. J. M. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012880 · Cited by 178
Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders
Petrakis, I. L., Poling, J., Levinson, C., Nich, C., Carroll, K., & Rounsaville, B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.016 · Cited by 177
Predicting response to opiate antagonists and placebo in the treatment of pathological gambling
Grant, J. E., Kim, S. W., Hollander, E., & Potenza, M. N. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1235-3 · Cited by 183
Alcohol- and drug-use disorders in Australia: implications of the National Survey of Mental Health and Wellbeing
Teesson, M., Hall, W., Lynskey, M. T., & Degenhardt, L. J. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2000.00715.x · Cited by 176
NALTREXONE, A RELAPSE PREVENTION MAINTENANCE TREATMENT OF ALCOHOL DEPENDENCE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Streeton, C. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.6.544 · Cited by 228
Alcoholism treatment adherence: older age predicts better adherence and drinking outcomes.
Oslin, D., Pettinati, H., & Volpicelli, J. (2002) · The American journal of geriatric psychiatry · doi:10.1097/00019442-200211000-00013 · Cited by 150
Self-citation
Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism
Sinclair, J. D. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.1.2 · Cited by 175
A 6‐Month Controlled Naltrexone Study: Combined Effect With Cognitive Behavioral Therapy in Outpatient Treatment of Alcohol Dependence
Balldin, J., Berglund, M., Borg, S., Månsson, M., Bendtsen, P., Franck, J., Gustafsson, L., Halldin, J., Nilsson, L. ‐. H., Stolt, G., et al. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000075548.83053.a9 · Cited by 173
Conceptual framework for the etiology of alcoholism: a “kindling”/stress hypothesis
Breese, G. R., Overstreet, D. H., & Knapp, D. J. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2016-2 · Cited by 167
Neuropharmacological treatments for alcoholism: scientific basis and clinical findings
Johnson, B. A., & Ait‐Daoud, N. (2000) · Psychopharmacology · doi:10.1007/s002130000371 · Cited by 172
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Burnette, E. M., Nieto, S. J., Grodin, E. N., Meredith, L. R., Hurley, B., Miotto, K., Gillis, A. J., & Ray, L. A. (2022) · Drugs · doi:10.1007/s40265-021-01670-3 · Cited by 169
Staff beliefs about addiction treatment
Forman, R. F., BOVASSO, G. B., & Woody, G. (2001) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(01)00173-8 · Cited by 170
The Status of Naltrexone in the Treatment of Alcohol Dependence
Pettinati, H. M., O’Brien, C. P., Rabinowitz, A. R., Wortman, S. P., Oslin, D. W., Kampman, K. M., & Dackis, C. A. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000245566.52401.20 · Cited by 171
Naltrexone Depot for Treatment of Alcohol Dependence: A Multicenter, Randomized, Placebo‐Controlled Clinical Trial
Kranzler, H. R., Wesson, D. R., Billot, L., & DrugAbuse Sciences Naltrexone Depot Study Group (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000130804.08397.29 · Cited by 169
REVIEW: Genetically selected Marchigian Sardinian alcohol‐preferring (msP) rats: an animal model to study the neurobiology of alcoholism
Ciccocioppo, R., Economidou, D., Cippitelli, A., Cucculelli, M., Ubaldi, M., Soverchia, L., Lourdusamy, A., & Massi, M. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00032.x · Cited by 170
Endogenous opioids and reward
Van Ree, J. M., Niesink, R. J. M., Van Wolfswinkel, L., Ramsey, N. F., Kornet, M. (. ). M. W., Van Furth, W. R., Vanderschuren, L. J. M. J., Gerrits, M. A. F. M., & Van den Berg, C. L. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00544-6 · Cited by 166
Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi‐centre, randomized, double‐blind, placebo‐controlled trial
Morley, K. C., Teesson, M., Reid, S., Sannibale, C., Thomson, C., Phung, N., Weltman, M., Bell, J. R., Richardson, K., & Haber, P. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01555.x · Cited by 165
Effects of Naltrexone on Alcohol Self-Administration in Heavy Drinkers
Davidson, D., Palfai, T. P., Bird, C., & Swift, R. M. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04099.x · Cited by 165
IMPLICATIONS OF ENDOGENOUS OPIOIDS AND DOPAMINE IN ALCOHOLISM: HUMAN AND BASIC SCIENCE STUDIES
Gianoulakis, C. (1996) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008216 · Cited by 162
SUBTYPES OF ALCOHOLISM AND THEIR ROLE IN THERAPY
LESCH, O. M., & WALTER, H. (1996) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008221 · Cited by 164
How Can We Use Our Knowledge of Alcohol-Tobacco Interactions to Reduce Alcohol Use?
McKee, S. A., & Weinberger, A. H. (2012) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185549 · Cited by 164
Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study
Grant, J. E., Odlaug, B. L., Potenza, M. N., Hollander, E., & Kim, S. W. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.110.078105 · Cited by 162
The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk
Zhang, H.-P., Kranzler, H., Yang, B.-Z., Luo, X.-G., & Gelernter, J. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002035 · Cited by 174
Alcohol craving predicts drinking during treatment: an analysis of three assessment instruments.
Flannery, B., Poole, S. A., Gallop, R., & Volpicelli, J. R. (2003) · Journal of Studies on Alcohol · doi:10.15288/jsa.2003.64.120 · Cited by 160
Self-citation
Development of pharmacotherapies for drug addiction: a Rosetta stone approach
Koob, G. F., Kenneth Lloyd, G., & Mason, B. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2828 · Cited by 154
The Relationship Between Substance Use Disorders, Impulse Control Disorders, and Pathological Aggression
Brady, K. T., Myrick, H., & McElroy, S. L. (1998) · American Journal on Addictions · doi:10.1111/j.1521-0391.1998.tb00340.x · Cited by 157
CONTRIBUTION OF FRONTAL CEREBRAL BLOOD FLOW MEASURED BY 99mTc-BICISATE SPECT AND EXECUTIVE FUNCTION DEFICITS TO PREDICTING TREATMENT OUTCOME IN ALCOHOL-DEPENDENT PATIENTS
Noel, X. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.4.347 · Cited by 153
Bridging the Gap: A Hybrid Model to Link Efficacy and Effectiveness Research in Substance Abuse Treatment
Carroll, K. M., & Rounsaville, B. J. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.3.333 · Cited by 155
Substance Use Disorders in the U.S. Armed Forces
Institute of Medicine (2013) · National Academies Press eBooks · doi:10.17226/13441 · Cited by 156
Association between two µ-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence
Zhang, H., Luο, X., Kranzler, H. R., Lappalainen, J., Yang, B., Krupitsky, E. M., Zvartau, E. E., & Gelernter, J. E. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl024 · Cited by 153
Testing Combined Pharmacotherapies and Behavioral Interventions in Alcohol Dependence: Rationale and Methods
The COMBINE Study Research Group (2003) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2003.tb02873.x · Cited by 174
μ-Opioid Receptor Knockout Mice Do Not Self-Administer Alcohol
Roberts, A. J., McDonald, J. S., Heyser, C. J., Kieffer, B. L., Matthes, H. W. D., Koob, G. F., & Gold, L. H. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39326-7 · Cited by 153
Treatment of Alcohol Abuse: An Evidence‐Based Review
Berglund, M., Thelander, S., Salaspuro, M. P., Franck, J., Andréasson, S., & Öjehagen, A. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000090144.99832.19 · Cited by 151
Differences in δ- and μ-Opioid Receptor Blockade Measured by Positron Emission Tomography in Naltrexone-Treated Recently Abstinent Alcohol-Dependent Subjects
Weerts, E. M., Kim, Y. K., Wand, G. S., Dannals, R. F., Lee, J. S., Frost, J. J., & McCaul, M. E. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301440 · Cited by 147
A framework for reporting outcomes in problem gambling treatment research: The Banff, Alberta consensus
Walker, M., Toneatto, T., Potenza, M. N., Petry, N., Ladouceur, R., Hodgins, D. C., El‐Guebaly, N., Echeburua, E., & Blaszczynski, A. (2006) · Addiction · doi:10.1111/j.1360-0443.2005.01341.x · Cited by 150
Sertraline in the Treatment of Co‐occurring Alcohol Dependence and Posttraumatic Stress Disorder
Brady, K. T., Sonne, S. C., Anton, R. F., Randall, C. L., Back, S. E., & Simpson, K. N. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000156129.98265.57 · Cited by 150
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Naltrexone, relapse prevention, and supportive therapy with alcoholics: An analysis of patient treatment matching.
Jaffe, A. J., Rounsaville, B. J., Chang, G., Schottenfeld, R. S., Meyer, R. E., & O'Malley, S. S. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.64.5.1044 · Cited by 149
Differences between Alcohol‐Preferring (AA) and Alcohol‐Avoiding (ANA) Rats in the Prodynorphin and Proenkephalin Systems
Nylander, I., Hyytiä, P., Forsander, O. A., & Terenius, L. Y. (1994) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00118.x · Cited by 141
Dopamine, Corticostriatal Connectivity, and Intertemporal Choice
Kayser, A. S., Allen, D. C., Cebrian, A. N., Mitchell, J., & Fields, H. L. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1180-12.2012 · Cited by 146
Opioid reward mechanisms: a key role in drug abuse?
Herz, A. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-76-3-252 · Cited by 146
The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference
Krishnan‐Sarin, S., Jing, S., Kurtz, D. L., Zweifel, M., Portoghese, P. S., Li, T., & Froehlich, J. C. (1995) · Psychopharmacology · doi:10.1007/bf02246191 · Cited by 145
Bipolar disorder and substance abuse
LEVIN, F. R., & Hennessy, G. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.05.008 · Cited by 144
Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity?
Bart, G. B., Schluger, J. H., Borg, L., Ho, A., Bidlack, J. M., & Kreek, M. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300811 · Cited by 145
Naltrexone as an Adjunctive Treatment for Older Patients With Alcohol Dependence
Oslin, D. W., Liberto, J. G., O'Brien, J. T., Krois, S., & Norbeck, J. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199700540-00007 · Cited by 143
Prevention, screening, and treatment for heavy drinking and alcohol use disorder
Knox, J., Hasin, D. S., Larson, F. R. R., & Kranzler, H. R. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30213-5 · Cited by 158
Initial and Maintenance Naltrexone Treatment for Alcohol Dependence Using Primary Care vs Specialty Care
O’Malley, S. S., Rounsaville, B. J., Farren, C. K., Namkoong, K., Wu, R., Robinson, J., & O’Connor, P. G. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.14.1695 · Cited by 141
Carbohydrate‐Deficient Transferrin and γ‐Glutamyltransferase for the Detection and Monitoring of Alcohol Use: Results From a Multisite Study
Anton, R. F., Lieber, C. S., & Tabakoff, B. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02658.x · Cited by 142
Central Administration of an Opiate Antagonist Decreases Oral Ethanol Self-Administration in Rats
Heyser, C. J., Roberts, A. J., Schulteis, G., & Koob, G. F. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04669.x · Cited by 141

Authors: Volpicelli, J. R.
Affiliations: University of Pennsylvania (US)
Corresponding author: Volpicelli, Joseph R.
ORCID: Volpicelli, Joseph R.
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 1992-11-01
Volume: 49
Issue: 11
Pages: 876
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archpsyc.1992.01820110040006
OpenAlex: W2104538950
Cited by: 1,828
References: 23
Citations by year: 2026: 7 · 2025: 10 · 2024: 17 · 2023: 15 · 2022: 25 · 2021: 17 · 2020: 28 · 2019: 26 · 2018: 29 · 2017: 26 · 2016: 32 · 2015: 48 · 2014: 49 · 2013: 47 · 2012: 58
FWCI: 36.57
Type: journal article
Language: en
Open access: closed
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Alcohol Abuse and Alcoholism (AA0751701A1)
National Institute on Drug Abuse (DA-05186)
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
Keywords: naltrexone, alcoholism, alcohol craving, alcohol relapse prevention, alcohol detoxification, outpatient care, opioid antagonists, adjunct pharmacotherapy, nausea, arthritic pain
MeSH terms: Adult, Alcohol Drinking, Alcoholism, Ambulatory Care, Combined Modality Therapy, Double-Blind Method, Humans, Male, Naltrexone, Nausea, Patient Dropouts, Placebos, Psychiatric Status Rating Scales, Psychotherapy, Recurrence, Severity of Illness Index, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Naltrexone in the Treatment of Alcohol Dependence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks